Patent · US Active

Pyridylpyridone compounds

US11219618B2 · kind B2 · utility

2Cited by

0References

17Claims

0Family size

Assignee

Sprint Bioscience AB · SE

Inventors

Johan Lindström · Huddinge, SE
Rickard Forsblom · Tullinge, SE
Tobias Ginman · Tullinge, SE
Fredrik Rahm · Huddinge, SE
Jenny Viklund · Kungshättan, SE

Key dates

Filing date	Aug 23, 2018
Grant date	Jan 11, 2022
Priority date	—
Expiry date	Aug 23, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/027
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel pyridylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and X are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.